ペムブロリズマブと化学療法,または化学療法単独で進行した食道がんの第一線治療 (KEYNOTE-590):ランダム化,プラセボ対照,第3相試験
Jong-Mu Sun1, Lin Shen2, Manish A Shah3
1Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea.
Lancet (London, England)
|August 29, 2021
まとめ
ペムブロリズマブと化学療法は,進行性食道がん患者の全生存期間と進行性のない生存期間を有意に改善しました. この組み合わせ治療は,新しい第一線治療の選択肢を提供する,管理可能な安全性プロファイルを示しました.
科学分野:
- 腫瘍学
- 免疫療法
- 胃腸腫瘍学
背景:
- 進んだ食道癌の現在の第一線治療は,フッ素ピリミジンとプラチナベースの化学療法に依存しています.
- 治療の選択肢が限られているため,新しい治療戦略を探求する必要があります.
研究 の 目的:
- ペムブロリズマブと化学療法による抗腫瘍活性と,単独の化学療法による抗腫瘍活性を評価する.
- 進んだ食道癌と胃食道癌の第一線治療としてのペムブロリズマブの有効性と安全性を評価する.
主な方法:
- 168のセンターで749人の患者を対象としたランダム化,プラセボ対照,ダブルブラインド,第3相試験です.
- 患者は3週間ごとにペンブロリズマブまたはプラセボを5 - フロロウラシールとシスプラチンと併用した.
- 主要エンドポイントは,地域,組織学,およびパフォーマンス状態によって層分かれ,全生存率および進行性のない生存率でした.
主要な成果:
- ペムブロリズマブと化学療法は,食道状細胞癌とPD- L1 CPS ≥10 (13. 9 vs 8. 8ヶ月) の患者で優れた全生存期間を示した.
- すべてのランダム化された患者を含む様々な患者サブグループで,進行性のない生存率の有意な改善が観察されました.
- 3度またはそれ以上の治療に関連する有害事象は,ペムブロリズマブとプラセボ群の間で比較可能でした (72% vs 68%).
結論:
- ペムブロリズマブと化学療法は,進行した食道がんの第一線治療において,重要な進歩を示しています.
- 併用療法により,治癒可能な安全性プロファイルで生存率が向上します.
- この研究は,ペムブロリズマブと化学療法を適格な患者に対する新しい標準治療として支持しています.
さらに関連する動画
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.8K
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
5.2K
関連する概念動画
Cancer Therapies
8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
